Yuki Katsuyuki, Ikeda Naohiro, Nishiyama Naohiro, Kasamatsu Toshio
R&D-Safety Science Research, Kao Corporation, 2606 Akabane, Ichikai-Machi, Haga-Gun, Tochigi 321-3497, Japan.
Mutat Res Genet Toxicol Environ Mutagen. 2013 Oct 9;757(2):148-57. doi: 10.1016/j.mrgentox.2013.08.001. Epub 2013 Aug 27.
The high rate of false-positive or misleading results in in vitro mammalian genotoxicity testing is a hurdle in the development of valuable chemicals, especially those used in cosmetics, for which in vivo testing is banned in the European Union. The reconstructed skin micronucleus (RSMN) assay in EpiDerm™ (MatTek Corporation, USA) has shown promise as a follow-up for positive in vitro mammalian genotoxicity tests. However, few studies have explored its better predictive performance compared with existing in vitro assays. In the present study, we followed the protocol of the RSMN assay and used eight chemicals to compare micronucleus (MN) induction with EpiDerm™ with that in normal human epidermal keratinocytes (NHEKs), both derived from human skin. The assessments of EpiDerm™ conformed to those of in vivo MN assay, whereas those of NHEKs did not. The effect of cell differentiation status on MN induction was further addressed using a model compound, epigallocatechin gallate (EGCG), which is a major component of green tea extract that shows positive results in in vitro mammalian genotoxicity assays via oxidative stress and negative results in in vivo MN studies. RSMN assay in an underdeveloped epidermal model, EpiDerm-201™ (MatTek Corporation), showed a negative result identical to that in EpiDerm™, indicating that the barrier function of keratinocytes has limited impact. Analysis of the gene expression profile of both EpiDerm™ and NHEKs after EGCG treatment for 12h revealed that the expression of genes related to genotoxic response was significantly induced only in NHEKs. Conversely, antioxidative enzyme activities (catalase and glutathione peroxidase) in EpiDerm™ were higher than those in NHEKs. These results indicate that EpiDerm™ has antioxidant properties similar to those of a living body and is capable of eliminating oxidative stress that may be caused by EGCG under in vitro experimental conditions.
体外哺乳动物遗传毒性测试中假阳性或误导性结果的高发生率,是有价值化学品开发过程中的一个障碍,尤其是用于化妆品的化学品,在欧盟,此类化学品禁止进行体内测试。美国MatTek公司的EpiDerm™重建皮肤微核(RSMN)试验,已显示出有望作为体外哺乳动物遗传毒性阳性测试的后续试验。然而,与现有的体外试验相比,很少有研究探讨其更好的预测性能。在本研究中,我们遵循RSMN试验方案,使用8种化学品比较EpiDerm™与源自人皮肤的正常人表皮角质形成细胞(NHEK)中微核(MN)的诱导情况。EpiDerm™的评估结果与体内MN试验的评估结果一致,而NHEK的评估结果则不然。使用模型化合物表没食子儿茶素没食子酸酯(EGCG)进一步探讨细胞分化状态对MN诱导的影响,EGCG是绿茶提取物的主要成分,在体外哺乳动物遗传毒性试验中通过氧化应激显示阳性结果,而在体内MN研究中显示阴性结果。在未成熟表皮模型EpiDerm-201™(MatTek公司)中进行的RSMN试验显示出与EpiDerm™相同的阴性结果,表明角质形成细胞的屏障功能影响有限。对EGCG处理12小时后的EpiDerm™和NHEK的基因表达谱分析表明,仅在NHEK中显著诱导了与遗传毒性反应相关的基因表达。相反,EpiDerm™中的抗氧化酶活性(过氧化氢酶和谷胱甘肽过氧化物酶)高于NHEK中的。这些结果表明,EpiDerm™具有与活体相似的抗氧化特性,并且能够在体外实验条件下消除可能由EGCG引起的氧化应激。